RESPONSE: Re: Active Tamoxifen Metabolite Plasma Concentrations After Coadministration of Tamoxifen and the Selective Serotonin Reuptake Inhibitor Paroxetine

J Natl Cancer Inst 2003;95:1758 64.(2) Early Breast Cancer Trialists CollaborativeGroup. Tamoxifen for early breast cancer: anoverview of the randomised trials. Lancet1998;351:1451 67.(3) Decensi A, Bonanni B, Guerrieri-Gonzaga A,Gandini S, Robertson C, Johansson H, et al.Biologic activity of tamoxi...

Full description

Saved in:
Bibliographic Details
Published in:JNCI : Journal of the National Cancer Institute 2004-06, Vol.96 (11), p.884-885
Main Authors: Stearns, Vered, Johnson, Michael D., Rae, James M., Novielli, Antonella, Bhargava, Pankaj, Hayes, Daniel F., Desta, Zeruesenay, Flockhart, David A.
Format: Article
Language:English
Subjects:
Breast cancer
Drug therapy
Plasma
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:J Natl Cancer Inst 2003;95:1758 64.(2) Early Breast Cancer Trialists CollaborativeGroup. Tamoxifen for early breast cancer: anoverview of the randomised trials. Lancet1998;351:1451 67.(3) Decensi A, Bonanni B, Guerrieri-Gonzaga A,Gandini S, Robertson C, Johansson H, et al.Biologic activity of tamoxifen at low doses inhealthy women. J Natl Cancer Inst 1998;90:14617.(4) Decensi A, Robertson C, Viale G, Pigatto F,Johansson H, Kisanga ER, et al.
ISSN:0027-8874
1460-2105
DOI:10.1093/jnci/djh162